CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; Food and Drug Administration (FDA) related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Issues related to international trade including the United States-Mexico-Canada Agreement (USMCA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Implementation of Tax Cuts and Jobs Act (P.L.115-97).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Issues related to pharmaceutical patents; S.1416, Affordable Prescriptions for Patients Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, and the international pharmaceutical supply chain. Implementation of 21st Century Cures Act (P.L.114-255). S.1895, Lower Health Care Costs Act of 2019. Education around COVID-19 therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, such as: Part D Medicare Program, Medicare Part B reimbursement, and drug pricing. Proposed Part B IPI Demonstration Project. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.